Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Cuanluan Fang is a Traditional Chinese Medicine (TCM) formula developed for the treatment of anovulatory infertility and related reproductive disorders. The formula is designed to tonify the 'Kidney' system in TCM theory, which is closely linked to reproductive function, and to promote ovulation (Culuan). It is being investigated in clinical trials for a variety of conditions including polycystic ovarian syndrome (PCOS), hyperprolactinemia, luteinized unruptured follicle syndrome (LUFS), and diminished ovarian response. Research, including adaptive multicenter clinical trials led by Xiyuan Hospital of the China Academy of Chinese Medical Sciences, evaluates its effectiveness both as a standalone therapy and in combination with Western medications like Clomiphene. The formula is typically administered as an oral decoction or in granule form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Cuanluan Fang.